Intracardiac Echocardiography in Atrial Flutter Ablation
FLS-ICE-R
The Usefulness of Intracardiac Echocardiography in Atrial Flutter Ablation - a Randomized Study
1 other identifier
interventional
79
1 country
1
Brief Summary
Background: Radiofrequency ablation of typical atrial flutter present the most effective treament option in treatment of atrial flutter. Despite its high efficacy, due tovariant anatomy of cavotricuspid isthmus (CTI), i.e. location of right coronary artery, pouches, the achievment of complete bidirectional block across the CTI is sometimes chalenging. Intracardiac echocardiography (ICE) is a very usefull tool for on-line vizualization of the anatomy of the atria and also for the location of catheter position on CTI during ablation. If the routine use of ICE is associated with easier atrial fluter ablation is not clear. Methods: One hundred consecutive patients indicated for typical atrial flutter ablation will be enrolled into the study. The patients will be randomized into group (A) ablation with use of ICE and (B) ablation without ICE. The ablation will be done in both groups by two diagnostic catheters (10-pole positioned in coronary sinus and 20-pole halo catheter positioned in the right atrium) and radiofrequency ablation catheter. The end-point of the ablation is the achievment of the bicidrectional block across the CTI. The end-points of the study are 1) the total length of the procedure, 2) the fluoroscopy time and 3) the ablation time. The safety end-point is clinically significant bleeding from the groin due to additional puncture for ICE catheter. Discussion: We hypothesize the use of ICE wil shorten the radiofrequency energy delivery, fluoroscopy time and the length of the procedure without increasing the bleeding.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jun 2014
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 22, 2015
CompletedFirst Posted
Study publicly available on registry
April 27, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2017
CompletedJanuary 31, 2019
January 1, 2019
2.9 years
April 22, 2015
January 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Procedure duration
The total lenght of the procedure in minuts will be measured.
intraoperative
Fluoroscopy time during ablation
The total fluoroscopy time will be measured.
intraoperative
Total ablation time
The time of radiofrequenc energy delivery during ablation will me measured.
intraoperative
Bleeding
The bleeding complication required intervention or prolonged hospitalization will be measured.
24 hours
Study Arms (2)
Flutter ablation with intracardiac echocardiography
EXPERIMENTALAtrial flutter ablation will be done using intracardiac echocardiography.
Flutter ablation without intracardiac echocardiography
ACTIVE COMPARATORAtrial flutter ablation will be done without intracardiac echocardiography.
Interventions
Flutter ablation will be done using intracardiac echocardiography.
Eligibility Criteria
You may qualify if:
- indication for atrial flutter ablation
You may not qualify if:
- history of recent femoral vein thrombosis (within last 6 months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardiocenter, 3rd Medical School, Charles University and University Hospital Kralovske Vinohrady
Prague, 10034, Czechia
Related Publications (7)
Scaglione M, Caponi D, Di Donna P, Riccardi R, Bocchiardo M, Azzaro G, Leuzzi S, Gaita F. Typical atrial flutter ablation outcome: correlation with isthmus anatomy using intracardiac echo 3D reconstruction. Europace. 2004 Sep;6(5):407-17. doi: 10.1016/j.eupc.2004.05.008.
PMID: 15294265BACKGROUNDLee G, Sanders P, Kalman JM. Catheter ablation of atrial arrhythmias: state of the art. Lancet. 2012 Oct 27;380(9852):1509-19. doi: 10.1016/S0140-6736(12)61463-9.
PMID: 23101718RESULTSchumacher B, Pfeiffer D, Tebbenjohanns J, Lewalter T, Jung W, Luderitz B. Acute and long-term effects of consecutive radiofrequency applications on conduction properties of the subeustachian isthmus in type I atrial flutter. J Cardiovasc Electrophysiol. 1998 Feb;9(2):152-63. doi: 10.1111/j.1540-8167.1998.tb00896.x.
PMID: 9511889RESULTGami AS, Edwards WD, Lachman N, Friedman PA, Talreja D, Munger TM, Hammill SC, Packer DL, Asirvatham SJ. Electrophysiological anatomy of typical atrial flutter: the posterior boundary and causes for difficulty with ablation. J Cardiovasc Electrophysiol. 2010 Feb;21(2):144-9. doi: 10.1111/j.1540-8167.2009.01607.x. Epub 2009 Oct 5.
PMID: 19804553RESULTLai LP, Lin JL, Lin JM, Du CC, Tseng YZ, Huang SK. Use of double-potential barrier to identify functional isthmus at the cavotricuspid isthmus for facilitating catheter ablation of isthmus-dependent atrial flutter. J Cardiovasc Electrophysiol. 2004 Apr;15(4):396-401. doi: 10.1046/j.1540-8167.2004.03424.x.
PMID: 15089986RESULTAl Aloul B, Sigurdsson G, Can I, Li JM, Dykoski R, Tholakanahalli VN. Proximity of right coronary artery to cavotricuspid isthmus as determined by computed tomography. Pacing Clin Electrophysiol. 2010 Nov;33(11):1319-23. doi: 10.1111/j.1540-8159.2010.02844.x.
PMID: 20663073RESULTMorton JB, Sanders P, Davidson NC, Sparks PB, Vohra JK, Kalman JM. Phased-array intracardiac echocardiography for defining cavotricuspid isthmus anatomy during radiofrequency ablation of typical atrial flutter. J Cardiovasc Electrophysiol. 2003 Jun;14(6):591-7. doi: 10.1046/j.1540-8167.2003.02152.x.
PMID: 12875419RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Cardiocenter, III rd internal-cardiology clinic
Study Record Dates
First Submitted
April 22, 2015
First Posted
April 27, 2015
Study Start
June 1, 2014
Primary Completion
April 10, 2017
Study Completion
April 10, 2017
Last Updated
January 31, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share
Study was published